Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesSleep MedicineRegence Phrenic Nerve Stimulation Coverage | OpenP…
    Ask Trek AI about this page
    CurrentRegencePolicy 212

    Phrenic Nerve Stimulation for Central Sleep Apnea

    Customize your policy alerts

    Sign up for regence Policy 212 alerts

    Get alerted when Policy 212 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of phrenic nerve stimulation for members with central sleep apnea. Regence considers this treatment investigational and not covered.

    Policy Summary
    PayerRegence
    PolicyPhrenic Nerve Stimulation for Central Sleep Apnea
    Policy CodePolicy 212
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewSep 1, 2026
    Next Review DateJune 1, 2027
    Key ActionInform members before rendering phrenic nerve stimulation that they may be financially responsible because the service is investigational and not covered.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    InvestigationalCoverage status for phrenic nerve stimulation
    1FDA-approved phrenic nerve stimulation devices identified

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Very lowCertainty of evidence in the 2025 AASM recommendation
    9CPT codes listed
    2HCPCS codes listed

    Coverage Criteria

    Phrenic Nerve Stimulation for Central Sleep Apnea

    Coverage determination:

    Investigational service: Phrenic nerve stimulation for central sleep apnea is considered investigational and is not covered.

    Central Sleep Apnea

    Coverage determination:

    Investigational status: Phrenic nerve stimulation for the treatment of central sleep apnea is considered investigational because available research is insufficient to determine whether, or how well, it improves health outcomes.

    Evidence includes one randomized controlled trial and observational studies. No randomized controlled trial compared phrenic nerve stimulation with positive airway pressure or respiratory stimulant medication.

    Phrenic nerve stimulation for central sleep apnea is considered investigational and is not covered under this policy. Coverage determinations are made under the applicable member contract, and contract language takes precedence if it conflicts with the policy. Contracts may exclude investigational services; providers should inform members before treatment that they may be financially responsible for the service.

    Coding Information

    FDA Product Codemixed
    PSRProduct code for the remedē System
    CPT codesCPTExperimental
    33276Insertion of phrenic nerve stimulator system (pulse generator and stimulating lead[s]), including vessel catheterization, all imaging guidance, and pulse generator initial analysis with diagnostic mode activation, when performed.
    33277Insertion of phrenic nerve stimulator transvenous sensing lead (List separately in addition to code for primary procedure).
    33278Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed.
    33281Repositioning of phrenic nerve stimulator transvenous lead(s).
    33287Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed.
    CPTCPT
    33276Insertion of phrenic nerve stimulator system (pulse generator and stimulating lead[s]), including vessel catheterization, all imaging guidance, and pulse generator initial analysis with diagnostic mode activation, when performed.
    33277Insertion of phrenic nerve stimulator transvenous sensing lead (List separately in addition to code for primary procedure).
    33278Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; system, including pulse generator and lead(s).
    33281Repositioning of phrenic nerve stimulator transvenous lead(s).
    33287Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator.
    93150Therapy activation of implanted phrenic nerve stimulator system, including all interrogation and programming.
    93151Interrogation and programming (minimum one parameter) of implanted phrenic nerve stimulator system.
    93152Interrogation and programming of implanted phrenic nerve stimulator system during polysomnography.
    93153Interrogation without programming of implanted phrenic nerve stimulator system.
    HCPCSHCPCS
    C1823Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads.
    L8697External accessory for use with implantable phrenic nerve stimulation device.
    Apnea-Hypopnea Index severity
    NormalAHI <5 events per hour
    MildAHI 5 to <15 events per hour
    ModerateAHI 15 to <30 events per hour
    SevereAHI >30 events per hour
    Epworth Sleepiness Scale
    Excessive sleepinessESS score over 10

    Provider Actions

    Denial Risk

    Investigational Treatment — Not Covered

    Phrenic nerve stimulation for the treatment of central sleep apnea (CSA) is considered investigational and is not covered under this policy.

    Billing Rule

    Contract Exclusion and Member Liability

    Applicable contracts exclude services or procedures considered investigational or cosmetic. Providers may bill members for these services and should inform members before rendering them that they are likely to be financially responsible for the cost.

    Note

    Background

    Central sleep apnea (CSA) is characterized by repeated cessation or reduction of airflow and ventilatory effort during sleep. It may be idiopathic or secondary to conditions including heart failure, stroke, medication use, or high-altitude breathing. A cited community cohort estimated CSA prevalence at 0.9%.

    Treatment context may include management of underlying conditions and other sleep-related therapies. Phrenic nerve stimulation uses an implanted system to stimulate a phrenic nerve and activate the diaphragm, with the goal of restoring a more normal breathing pattern. The remedē System was identified as an FDA-approved phrenic nerve stimulation device in 2017; however, available evidence remains insufficient to determine whether or how well phrenic nerve stimulation improves health outcomes. The policy therefore considers this treatment investigational for CSA.

    Definitions and Abbreviations

    Central sleep apnea (CSA)
    DefinitionRepetitive cessation or decrease in both airflow and ventilatory effort during sleep.
    Apnea-Hypopnea Index (AHI)
    DefinitionThe number of apnea and hypopnea events per hour of sleep.
    Normal in adultsAHI <5 events per hour
    Mild in adultsAHI 5 to <15 events per hour
    Moderate in adultsAHI 15 to <30 events per hour
    Severe in adultsAHI >30 events per hour
    Policy Summary
    PayerRegence
    PolicyPhrenic Nerve Stimulation for Central Sleep Apnea
    Policy CodePolicy 212
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewSep 1, 2026
    Next Review DateJune 1, 2027
    Key ActionInform members before rendering phrenic nerve stimulation that they may be financially responsible because the service is investigational and not covered.
    SourceLink
    On This Page
    Coverage CriteriaCoding InformationProvider ActionsBackgroundDefinitions and Abbreviations

    Insufficient Evidence Supports Investigational Designation

    There is insufficient research to determine whether or how well phrenic nerve stimulation treats CSA. No clinical practice guidelines based on high-quality research recommend this treatment for this population; therefore, it remains investigational.

    Central apnea index (CAI)
    DefinitionThe number of central apnea events per hour of sleep.
    Epworth Sleepiness Scale (ESS)
    PurposeA self-administered questionnaire measuring the likelihood of falling asleep in eight situations.
    Scoring range0 to 24 points; each situation is scored from 0 (no chance) to 3 (high chance).
    InterpretationScores over 10 indicate excessive sleepiness and a recommendation to seek medical attention.
    Abbreviation
    CAICentral apnea index.
    Abbreviation
    AHIApnea-Hypopnea Index.
    Abbreviation
    ESSEpworth Sleepiness Scale.
    Abbreviation
    CSACentral sleep apnea.
    Abbreviation
    HFHeart failure.
    Abbreviation
    PGAPatient Global Assessment.
    Abbreviation
    TPNSTransvenous phrenic nerve stimulation.